HEADER TRANSPORT PROTEIN 16-NOV-17 6EZQ TITLE HUMAN SERUM ALBUMIN COMPLEXED WITH NBD-C12 FATTY ACID COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERUM ALBUMIN; COMPND 3 CHAIN: A SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 TISSUE: SERUM KEYWDS FATTY ACID BINDING SITE HUMAN SERUM ALBUMIN NBD LABEL DRUG KEYWDS 2 INTERACTION, TRANSPORT PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR L.WENSKOWSKY,A.LIESUM,H.A.SCHREUDER REVDAT 3 09-OCT-24 6EZQ 1 REMARK REVDAT 2 24-JAN-18 6EZQ 1 JRNL REVDAT 1 13-DEC-17 6EZQ 0 JRNL AUTH L.WENSKOWSKY,H.SCHREUDER,V.DERDAU,H.MATTER,J.VOLKMAR, JRNL AUTH 2 M.NAZARE,T.OPATZ,S.PETRY JRNL TITL IDENTIFICATION AND CHARACTERIZATION OF A SINGLE JRNL TITL 2 HIGH-AFFINITY FATTY ACID BINDING SITE IN HUMAN SERUM JRNL TITL 3 ALBUMIN. JRNL REF ANGEW. CHEM. INT. ED. ENGL. V. 57 1044 2018 JRNL REFN ESSN 1521-3773 JRNL PMID 29193545 JRNL DOI 10.1002/ANIE.201710437 REMARK 2 REMARK 2 RESOLUTION. 2.39 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.7 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.39 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 115.79 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 55.1 REMARK 3 NUMBER OF REFLECTIONS : 13144 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.187 REMARK 3 R VALUE (WORKING SET) : 0.182 REMARK 3 FREE R VALUE : 0.298 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.650 REMARK 3 FREE R VALUE TEST SET COUNT : 611 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 7 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.39 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.58 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 4.84 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 236 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2469 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 224 REMARK 3 BIN R VALUE (WORKING SET) : 0.2435 REMARK 3 BIN FREE R VALUE : 0.3064 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.08 REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4426 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 54 REMARK 3 SOLVENT ATOMS : 324 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 60.21 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 50.13 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.71810 REMARK 3 B22 (A**2) : 0.99860 REMARK 3 B33 (A**2) : -2.71670 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 1.18390 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.310 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.529 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.935 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.818 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4582 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 6189 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1637 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 123 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 650 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4582 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 583 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 5673 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.26 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.71 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 24.33 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6EZQ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 16-NOV-17. REMARK 100 THE DEPOSITION ID IS D_1200007524. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-APR-17 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06DA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.99992 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M-F REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS (VERSION JUN 1, XDS JUN 1, REMARK 200 2017 REMARK 200 DATA SCALING SOFTWARE : AUTOPROC (VERSION 1.1.7), REMARK 200 STARANISO REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 13145 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.390 REMARK 200 RESOLUTION RANGE LOW (A) : 115.790 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 55.3 REMARK 200 DATA REDUNDANCY : 3.200 REMARK 200 R MERGE (I) : 0.08400 REMARK 200 R SYM (I) : 0.08400 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 8.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.39 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.73 REMARK 200 COMPLETENESS FOR SHELL (%) : 8.5 REMARK 200 DATA REDUNDANCY IN SHELL : 3.40 REMARK 200 R MERGE FOR SHELL (I) : 0.62000 REMARK 200 R SYM FOR SHELL (I) : 0.62000 REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: SLIGHTLY ORANGE CRYSTALS IN THE SHAPE OF STACKED PLATES REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.57 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.35 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: ESSENTIALLY DEFATTED HUMAN SERUM REMARK 280 ALBUMIN FROM SIGMA WAS PURIFIED BY SIZE EXCLUSION CHROMATOGRAPHY REMARK 280 TO OBTAIN PURE MONOMERIC PROTEIN. THE PURIFIED HSA WAS DISSOLVED REMARK 280 IN 50 MM POTASSIUM PHOSPHATE, 150 MM SODIUM CHLORIDE (PH 7.5) REMARK 280 AND CONCENTRATED TO 2 MM (140 MG/ML). THE HSA SOLUTION WAS REMARK 280 INCUBATED WITH A SIX FOLD EXCESS OF THE NBD-LABELLED FATTY ACID REMARK 280 AT 4-5 DEG.C FOR 4 HOURS. THE FINAL CONCENTRATION OF DIMETHYL REMARK 280 SULFOXIDE WAS 2% (V/V). THE CRYSTAL WAS GROWN BY THE HANGING REMARK 280 DROP VAPOR DIFFUSION METHOD USING A RESERVOIR SOLUTION REMARK 280 CONTAINING BUFFER (2.5 MM POTASSIUM PHOSPHATE, 7.5 MM SODIUM REMARK 280 CHLORIDE, PH 7.0), 0.3% GLYCEROL AND POLYETHYLENE GLYCOL 3350 (~ REMARK 280 30%). FOR CRYSTALLIZATION 1 UL OF HSA-LIGAND SOLUTION WAS REMARK 280 EQUILIBRATED AGAINST 1 UL OF RESERVOIR SOLUTION., VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 292K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 49.24000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 26.36000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 49.24000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 26.36000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 27560 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A 1 REMARK 465 ALA A 2 REMARK 465 THR A 79 REMARK 465 LEU A 80 REMARK 465 ARG A 81 REMARK 465 GLU A 82 REMARK 465 LYS A 500 REMARK 465 GLU A 501 REMARK 465 PHE A 502 REMARK 465 ASN A 503 REMARK 465 ALA A 504 REMARK 465 GLU A 505 REMARK 465 THR A 506 REMARK 465 PHE A 507 REMARK 465 THR A 508 REMARK 465 PHE A 509 REMARK 465 HIS A 510 REMARK 465 ALA A 511 REMARK 465 ASP A 512 REMARK 465 ILE A 513 REMARK 465 GLY A 584 REMARK 465 LEU A 585 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ALA A 78 C O REMARK 470 TYR A 84 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 LYS A 205 CD CE NZ REMARK 470 GLU A 396 CG CD OE1 OE2 REMARK 470 LYS A 444 CG CD CE NZ REMARK 470 GLU A 492 CG CD OE1 OE2 REMARK 470 GLU A 495 CG CD OE1 OE2 REMARK 470 LYS A 519 CG CD CE NZ REMARK 470 LYS A 524 CG CD CE NZ REMARK 470 GLU A 556 CG CD OE1 OE2 REMARK 470 ASP A 563 CG OD1 OD2 REMARK 470 GLU A 570 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 VAL A 493 C - N - CA ANGL. DEV. = 16.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 4 -56.57 -20.73 REMARK 500 ASN A 61 18.70 59.39 REMARK 500 VAL A 77 93.16 62.51 REMARK 500 GLU A 86 -29.18 77.56 REMARK 500 LYS A 93 -30.98 -35.79 REMARK 500 GLU A 95 139.04 58.93 REMARK 500 LEU A 112 137.45 -30.57 REMARK 500 VAL A 120 -70.39 -37.95 REMARK 500 HIS A 128 -67.54 75.47 REMARK 500 GLU A 132 -75.82 -51.22 REMARK 500 TYR A 150 98.72 -45.54 REMARK 500 GLU A 167 -19.07 -148.61 REMARK 500 PHE A 206 -15.04 -143.33 REMARK 500 ILE A 271 -76.68 -118.48 REMARK 500 ASP A 301 -116.03 61.57 REMARK 500 LEU A 302 129.62 80.15 REMARK 500 VAL A 310 -58.76 -131.41 REMARK 500 ALA A 363 171.20 -54.68 REMARK 500 LYS A 372 39.13 -88.27 REMARK 500 PHE A 374 -4.86 -59.52 REMARK 500 GLN A 390 -64.07 -167.51 REMARK 500 SER A 435 -89.65 -76.00 REMARK 500 ALA A 443 -35.03 -38.58 REMARK 500 VAL A 469 -36.09 -136.53 REMARK 500 THR A 478 -54.04 -135.48 REMARK 500 GLU A 479 -51.14 -23.94 REMARK 500 SER A 480 137.07 -179.30 REMARK 500 ASN A 483 38.07 -81.69 REMARK 500 GLU A 492 -49.93 -20.14 REMARK 500 VAL A 493 -160.80 164.01 REMARK 500 ASP A 494 -123.47 -90.86 REMARK 500 GLU A 495 -103.08 -143.90 REMARK 500 THR A 515 -98.84 -98.19 REMARK 500 LEU A 516 -30.74 71.11 REMARK 500 GLU A 518 -48.76 -147.74 REMARK 500 ASP A 562 36.30 -98.60 REMARK 500 ASP A 563 68.51 -162.43 REMARK 500 LYS A 564 -73.43 -43.68 REMARK 500 LYS A 574 -41.51 -131.85 REMARK 500 ALA A 577 43.16 -108.72 REMARK 500 ALA A 582 45.05 -90.95 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1005 DISTANCE = 5.91 ANGSTROMS REMARK 525 HOH A1006 DISTANCE = 5.93 ANGSTROMS REMARK 525 HOH A1007 DISTANCE = 6.01 ANGSTROMS REMARK 525 HOH A1008 DISTANCE = 6.15 ANGSTROMS REMARK 525 HOH A1009 DISTANCE = 6.20 ANGSTROMS REMARK 525 HOH A1010 DISTANCE = 6.22 ANGSTROMS REMARK 525 HOH A1011 DISTANCE = 6.36 ANGSTROMS REMARK 525 HOH A1012 DISTANCE = 6.52 ANGSTROMS REMARK 525 HOH A1013 DISTANCE = 6.56 ANGSTROMS REMARK 525 HOH A1014 DISTANCE = 6.58 ANGSTROMS REMARK 525 HOH A1015 DISTANCE = 6.64 ANGSTROMS REMARK 525 HOH A1016 DISTANCE = 6.65 ANGSTROMS REMARK 525 HOH A1017 DISTANCE = 6.66 ANGSTROMS REMARK 525 HOH A1018 DISTANCE = 7.11 ANGSTROMS REMARK 525 HOH A1019 DISTANCE = 7.53 ANGSTROMS REMARK 525 HOH A1020 DISTANCE = 7.88 ANGSTROMS REMARK 525 HOH A1021 DISTANCE = 7.91 ANGSTROMS REMARK 525 HOH A1022 DISTANCE = 8.29 ANGSTROMS REMARK 525 HOH A1023 DISTANCE = 9.48 ANGSTROMS REMARK 525 HOH A1024 DISTANCE = 9.94 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue C7K A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue C7K A 602 DBREF 6EZQ A 1 585 UNP P02768 ALBU_HUMAN 25 609 SEQRES 1 A 585 ASP ALA HIS LYS SER GLU VAL ALA HIS ARG PHE LYS ASP SEQRES 2 A 585 LEU GLY GLU GLU ASN PHE LYS ALA LEU VAL LEU ILE ALA SEQRES 3 A 585 PHE ALA GLN TYR LEU GLN GLN CYS PRO PHE GLU ASP HIS SEQRES 4 A 585 VAL LYS LEU VAL ASN GLU VAL THR GLU PHE ALA LYS THR SEQRES 5 A 585 CYS VAL ALA ASP GLU SER ALA GLU ASN CYS ASP LYS SER SEQRES 6 A 585 LEU HIS THR LEU PHE GLY ASP LYS LEU CYS THR VAL ALA SEQRES 7 A 585 THR LEU ARG GLU THR TYR GLY GLU MET ALA ASP CYS CYS SEQRES 8 A 585 ALA LYS GLN GLU PRO GLU ARG ASN GLU CYS PHE LEU GLN SEQRES 9 A 585 HIS LYS ASP ASP ASN PRO ASN LEU PRO ARG LEU VAL ARG SEQRES 10 A 585 PRO GLU VAL ASP VAL MET CYS THR ALA PHE HIS ASP ASN SEQRES 11 A 585 GLU GLU THR PHE LEU LYS LYS TYR LEU TYR GLU ILE ALA SEQRES 12 A 585 ARG ARG HIS PRO TYR PHE TYR ALA PRO GLU LEU LEU PHE SEQRES 13 A 585 PHE ALA LYS ARG TYR LYS ALA ALA PHE THR GLU CYS CYS SEQRES 14 A 585 GLN ALA ALA ASP LYS ALA ALA CYS LEU LEU PRO LYS LEU SEQRES 15 A 585 ASP GLU LEU ARG ASP GLU GLY LYS ALA SER SER ALA LYS SEQRES 16 A 585 GLN ARG LEU LYS CYS ALA SER LEU GLN LYS PHE GLY GLU SEQRES 17 A 585 ARG ALA PHE LYS ALA TRP ALA VAL ALA ARG LEU SER GLN SEQRES 18 A 585 ARG PHE PRO LYS ALA GLU PHE ALA GLU VAL SER LYS LEU SEQRES 19 A 585 VAL THR ASP LEU THR LYS VAL HIS THR GLU CYS CYS HIS SEQRES 20 A 585 GLY ASP LEU LEU GLU CYS ALA ASP ASP ARG ALA ASP LEU SEQRES 21 A 585 ALA LYS TYR ILE CYS GLU ASN GLN ASP SER ILE SER SER SEQRES 22 A 585 LYS LEU LYS GLU CYS CYS GLU LYS PRO LEU LEU GLU LYS SEQRES 23 A 585 SER HIS CYS ILE ALA GLU VAL GLU ASN ASP GLU MET PRO SEQRES 24 A 585 ALA ASP LEU PRO SER LEU ALA ALA ASP PHE VAL GLU SER SEQRES 25 A 585 LYS ASP VAL CYS LYS ASN TYR ALA GLU ALA LYS ASP VAL SEQRES 26 A 585 PHE LEU GLY MET PHE LEU TYR GLU TYR ALA ARG ARG HIS SEQRES 27 A 585 PRO ASP TYR SER VAL VAL LEU LEU LEU ARG LEU ALA LYS SEQRES 28 A 585 THR TYR GLU THR THR LEU GLU LYS CYS CYS ALA ALA ALA SEQRES 29 A 585 ASP PRO HIS GLU CYS TYR ALA LYS VAL PHE ASP GLU PHE SEQRES 30 A 585 LYS PRO LEU VAL GLU GLU PRO GLN ASN LEU ILE LYS GLN SEQRES 31 A 585 ASN CYS GLU LEU PHE GLU GLN LEU GLY GLU TYR LYS PHE SEQRES 32 A 585 GLN ASN ALA LEU LEU VAL ARG TYR THR LYS LYS VAL PRO SEQRES 33 A 585 GLN VAL SER THR PRO THR LEU VAL GLU VAL SER ARG ASN SEQRES 34 A 585 LEU GLY LYS VAL GLY SER LYS CYS CYS LYS HIS PRO GLU SEQRES 35 A 585 ALA LYS ARG MET PRO CYS ALA GLU ASP TYR LEU SER VAL SEQRES 36 A 585 VAL LEU ASN GLN LEU CYS VAL LEU HIS GLU LYS THR PRO SEQRES 37 A 585 VAL SER ASP ARG VAL THR LYS CYS CYS THR GLU SER LEU SEQRES 38 A 585 VAL ASN ARG ARG PRO CYS PHE SER ALA LEU GLU VAL ASP SEQRES 39 A 585 GLU THR TYR VAL PRO LYS GLU PHE ASN ALA GLU THR PHE SEQRES 40 A 585 THR PHE HIS ALA ASP ILE CYS THR LEU SER GLU LYS GLU SEQRES 41 A 585 ARG GLN ILE LYS LYS GLN THR ALA LEU VAL GLU LEU VAL SEQRES 42 A 585 LYS HIS LYS PRO LYS ALA THR LYS GLU GLN LEU LYS ALA SEQRES 43 A 585 VAL MET ASP ASP PHE ALA ALA PHE VAL GLU LYS CYS CYS SEQRES 44 A 585 LYS ALA ASP ASP LYS GLU THR CYS PHE ALA GLU GLU GLY SEQRES 45 A 585 LYS LYS LEU VAL ALA ALA SER GLN ALA ALA LEU GLY LEU HET C7K A 601 27 HET C7K A 602 27 HETNAM C7K 12-[(4-NITRO-2,1,3-BENZOXADIAZOL-7-YL)AMINO]DODECANOIC HETNAM 2 C7K ACID FORMUL 2 C7K 2(C18 H26 N4 O5) FORMUL 4 HOH *324(H2 O) HELIX 1 AA1 SER A 5 GLY A 15 1 11 HELIX 2 AA2 GLY A 15 LEU A 31 1 17 HELIX 3 AA3 PRO A 35 ASP A 56 1 22 HELIX 4 AA4 SER A 65 CYS A 75 1 11 HELIX 5 AA5 PRO A 96 HIS A 105 1 10 HELIX 6 AA6 GLU A 119 CYS A 124 1 6 HELIX 7 AA7 ASN A 130 HIS A 146 1 17 HELIX 8 AA8 TYR A 150 THR A 166 1 17 HELIX 9 AA9 LYS A 174 LYS A 205 1 32 HELIX 10 AB1 GLY A 207 PHE A 223 1 17 HELIX 11 AB2 GLU A 227 HIS A 247 1 21 HELIX 12 AB3 ASP A 249 ASN A 267 1 19 HELIX 13 AB4 GLN A 268 ILE A 271 5 4 HELIX 14 AB5 GLU A 277 LYS A 281 5 5 HELIX 15 AB6 PRO A 282 GLU A 292 1 11 HELIX 16 AB7 LEU A 305 VAL A 310 1 6 HELIX 17 AB8 ASP A 314 ALA A 322 1 9 HELIX 18 AB9 ALA A 322 HIS A 338 1 17 HELIX 19 AC1 SER A 342 CYS A 361 1 20 HELIX 20 AC2 ASP A 365 ALA A 371 1 7 HELIX 21 AC3 GLU A 376 VAL A 415 1 40 HELIX 22 AC4 SER A 419 CYS A 437 1 19 HELIX 23 AC5 PRO A 441 THR A 467 1 27 HELIX 24 AC6 SER A 470 SER A 480 1 11 HELIX 25 AC7 ASN A 483 ALA A 490 1 8 HELIX 26 AC8 LYS A 519 LYS A 536 1 18 HELIX 27 AC9 THR A 540 CYS A 559 1 20 HELIX 28 AD1 ASP A 563 GLU A 571 1 9 HELIX 29 AD2 LEU A 575 GLN A 580 1 6 SSBOND 1 CYS A 53 CYS A 62 1555 1555 2.02 SSBOND 2 CYS A 75 CYS A 91 1555 1555 2.04 SSBOND 3 CYS A 90 CYS A 101 1555 1555 2.04 SSBOND 4 CYS A 124 CYS A 169 1555 1555 2.04 SSBOND 5 CYS A 168 CYS A 177 1555 1555 2.04 SSBOND 6 CYS A 200 CYS A 246 1555 1555 2.04 SSBOND 7 CYS A 245 CYS A 253 1555 1555 2.04 SSBOND 8 CYS A 265 CYS A 279 1555 1555 2.03 SSBOND 9 CYS A 278 CYS A 289 1555 1555 2.04 SSBOND 10 CYS A 316 CYS A 361 1555 1555 2.03 SSBOND 11 CYS A 360 CYS A 369 1555 1555 2.04 SSBOND 12 CYS A 392 CYS A 438 1555 1555 2.04 SSBOND 13 CYS A 437 CYS A 448 1555 1555 2.05 SSBOND 14 CYS A 461 CYS A 477 1555 1555 2.05 SSBOND 15 CYS A 476 CYS A 487 1555 1555 2.04 SSBOND 16 CYS A 514 CYS A 559 1555 1555 2.04 SSBOND 17 CYS A 558 CYS A 567 1555 1555 2.04 CISPEP 1 GLU A 95 PRO A 96 0 -5.38 SITE 1 AC1 11 TYR A 150 LEU A 198 LYS A 199 SER A 202 SITE 2 AC1 11 PHE A 211 TRP A 214 ARG A 222 LEU A 238 SITE 3 AC1 11 HIS A 242 ARG A 257 HOH A 898 SITE 1 AC2 15 SER A 342 VAL A 344 LEU A 345 ARG A 348 SITE 2 AC2 15 PRO A 384 ILE A 388 ASN A 391 TYR A 411 SITE 3 AC2 15 VAL A 426 LEU A 430 LEU A 453 LEU A 457 SITE 4 AC2 15 ARG A 485 PHE A 488 SER A 489 CRYST1 98.480 52.720 123.300 90.00 110.10 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010154 0.000000 0.003716 0.00000 SCALE2 0.000000 0.018968 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008636 0.00000